Kavita K. Rao

picture of Kavita K. Rao

Health Sciences Assistant Clinical Professor, Ophthalmology
School of Medicine


M.D., Chicago Medical School, 2008
M.S., Chicago Medical School, 2004, Applied Physiology
B.A., University of California, Berkeley, 2003, Molecular & Cell Biology - Cell and Development Biology

Phone: Appointments: (949) 824-2020, Academic Office: (949) 824-7944
Fax: (949) 824-4015
Email: kkrao@uci.edu

University of California, Irvine
Department of Ophthalmology
Gavin Herbert Eye Institute
850 Health Sciences Road
Mail Code: 4375
Irvine, CA 92697
Research Interests
Ultrasound biomicroscopy as a tool in glaucoma evaluation, and intravitreal treatment for diabetic proliferative retinopathy
URLs
Research Abstract
Dept. of Ophthalmology, University of California, Irvine, 2020
· Principal Investigator – Marjan Farid, M.D.
· Sub-Investigator – Kavita Rao, M.D., M.S.
Risk Factors for Meibomian Gland Dysfunction in the Era of Meibography
The purpose of this research study is to understand the association of various potential risk factors (e.g.contact lens use, makeup, screen time, etc.) with meibomian gland dysfunction and associated changes on meibography. Meibomian gland dysfunction is a leading cause of dry eyes, which can decrease vision quality as well as quality of life. Meibography is a way to image the glands, often using infrared dynamic surface illumination. We will attempt to correlate changes in meibomian glands (dropout, truncation, etc.) to various risk factors that will be collected by survey or retrospective chart review.

Dept. of Urology, University of California, Irvine, 2017
· Principal Investigator – Gamal Ghoniem, M.D., FACS
· Sub-Investigator – Kavita Rao, M.D., M.S.
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind,
Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and
Safety of 2 Doses of AQX-1125 Targeting the SHIP1 Pathway in Subjects with Interstitial
Cystitis/Bladder Pain Syndrome Followed by 14 or 40-Week Extension Periods.
The purpose of this research study is to compare two dose levels of AQX-1125 (active study drug) to placebo (inactive study drug) in order determine which dose works best, how well the study drug is tolerated and how safe the study drug is in the treatment of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS). AQX-1125 caused eye toxicity in rat and dog animal studies. In rats, deterioration of the eye lens and cataracts (cloudy lens formation) were observed. Similar findings were seen in dogs at much higher doses. No similar changes have been seen in humans so far but the risk of developing cataracts with long term exposure, even after completing dosing, is currently unknown.
Publications
Rao, K., Ahmed, I. Black, D. Ayyala, R. New Devices in Glaucoma Surgery. Expert Review of Ophthalmology. 2009;4 (5), 491-504 January 2014.
 
Bell, N.P., Nagi, K.S., Cumba, R.J., Chuang, A.Z., Lee, D.A., Prager, T.C., Rao, K., Feldman R.M. Age and positional effect on the anterior chamber angle assessment by ultrasound biomicroscopy. ISRN Ophthalmol. 706201, 2013.
 
Rao, K., Syed, M.F., Feldman, R.M., Chuang, A.Z. Risk factors for progression to end stage glaucoma. Presented at the world glaucoma congress, Boston, MA. July 2009.
 
Tsai, PI., Kamat, K.K, Pathak, N., Danek K., Abuja R.M. Efficacy of intravitreal Bevacizumab in patients with proliferative diabetic retinopathy. Invest. Ophthalmol. Vis Sci. 49:E2736, 2008.
 
Eide, M.K., Tsai, P.I., Pathak, N.J, Kamat, K.K. Intravitreal Bevacizumab in patients with neovascular glaucoma. Invest. Ophthal. Vis. Sci. 49: E5590, 2008
 
Pathak, N.J, Tsai, P.I., Kamat, K.K., Riaz, K.M. Effect of Intravitreous injection of bevacizumab on systemic blood pressure. Invest. Ophthalmol. Vis Sci. 49: E5589, 2008.
Professional Societies
Orange County Society of Ophthalmology (OCSO) 2017
American Academy of Ophthalmology (AAO) 2017
American Association of Physicians of Indian Origin (AAPI) 2016 – Present
Other Experience
Clinical Specialist - General Ophthalmology
University of Texas MD Anderson Cancer Center 2013—2016

Residency, Ophthalmology
University of Texas Health Science Center at Houston 2010—2013

Internship, Internal Medicine
Baylor College of Medicine, Houston 2009—2010

Research Fellow, Department of Ophthalmology
University of Texas Health Science Center at Houston 2008—2009

Research Center
Gavin Herbert Eye Institute
Last updated
09/21/2021